financetom
Business
financetom
/
Business
/
Cenovus Energy acquires 8.5% of MEG Energy common shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cenovus Energy acquires 8.5% of MEG Energy common shares
Oct 14, 2025 3:05 AM

CALGARY, Alberta, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. ( CVE ) today announced that it has acquired an aggregate of 21,723,540 common shares of MEG Energy Corp. (“MEG”) through the facilities of the Toronto Stock Exchange or other Canadian alternative exchanges or markets. Immediately following the acquisition of the common shares, Cenovus beneficially owned, directly or indirectly, and exercised control or direction over an aggregate of MEG common shares representing 8.5% of the 254,378,035 MEG common shares issued and outstanding, all of which have been acquired by Cenovus since Oct. 8, 2025.

The MEG common shares were acquired by Cenovus in furtherance of its previously announced transaction with MEG. To the extent Cenovus is able, the company intends to vote any acquired shares in favour of the transaction. Cenovus may, from time to time, dependent on market or other conditions, and subject to applicable securities laws, either increase or decrease its beneficial ownership in the MEG common shares.

This news release is disseminated in accordance with section 5.4 of National Instrument 62-104 Take-Over Bids and Issuer Bids.

Advisory

Forward‐looking Information

This news release contains certain forward‐looking statements and forward‐looking information (collectively referred to as “forward‐looking information”) within the meaning of applicable securities legislation. Although Cenovus believes that the expectations represented by such forward‐looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Forward‐looking information in this document is identified by words such as “intends” and “may” and includes, but is not limited to, statements regarding: Cenovus’s intention to vote acquired shares in favour of its previously announced transaction with MEG; and regarding Cenovus’s future ownership in MEG common shares and its intentions related thereto. Developing forward‐looking information involves reliance on a number of assumptions and consideration of certain risks and uncertainties, including those risks identified under “Risk Management and Risk Factors” and “Advisory” in Cenovus’s Management’s Discussion and Analysis for the periods ended December 31, 2024 and June 30, 2025 and to the risk factors, assumptions and uncertainties described in other documents Cenovus files from time to time with securities regulatory authorities in Canada (available on SEDAR+ at sedarplus.ca, on EDGAR at sec.gov and Cenovus’s website at cenovus.com). Except as required by applicable securities laws, Cenovus disclaims any intention or obligation to publicly update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.

Cenovus Energy Inc. ( CVE )

Cenovus Energy Inc. ( CVE ) is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company is committed to maximizing value by developing its assets in a safe, responsible and cost-efficient manner, integrating environmental, social and governance considerations into its business plans. Cenovus common shares and warrants are listed on the Toronto and New York stock exchanges, and the company’s preferred shares are listed on the Toronto Stock Exchange. For more information, visit cenovus.com.

Find Cenovus on Facebook, LinkedIn, YouTube and Instagram.

Cenovus contacts

Investors Media
Investor Relations general line
403-766-7711
Media Relations general line
403-766-7751

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU0NDg0MyM3MTkzNjA3IzIwMDg3MDU=

Image: https://ml.globenewswire.com/media/ODQyOGJhOTMtMzQ2Yi00NDk1LWE0OWMtODFhODkxZDQ2ZDVkLTEwMjAyNzgtMjAyNS0xMC0xNC1lbg==/tiny/Cenovus-Energy-Inc-.png Image: Primary Logo

Source: Cenovus Energy Inc. ( CVE )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO Comments on Canada's Employment Rate
BMO Comments on Canada's Employment Rate
Sep 11, 2024
09:00 AM EDT, 09/10/2024 (MT Newswires) -- There's not much mystery around Canada's labor market -- the economy is grinding out modest job growth, but it can't come close to the still-torrid labor force/population growth, said Bank of Montreal (BMO). As a consequence, the unemployment rate continues to be higher, especially for young people, noted the bank. The flip side...
International Business Machines Adds Generative AI-Based Insights to ESPN Fantasy Football Platform
International Business Machines Adds Generative AI-Based Insights to ESPN Fantasy Football Platform
Sep 11, 2024
09:02 AM EDT, 09/10/2024 (MT Newswires) -- International Business Machines ( IBM ) said Tuesday it is updating Disney ( DIS ) backed ESPN's ( DIS ) fantasy football platform with new generative AI-based features. The company said the upgrades use IBM's ( IBM ) Granite large language model and watsonx platform to provide personalized player grades and clearer explanations...
What's Going On Goldman Sachs Stock Premarket Tuesday?
What's Going On Goldman Sachs Stock Premarket Tuesday?
Sep 11, 2024
The Goldman Sachs Group, Inc. ( GS ) shares are trading lower premarket Tuesday. On Monday, the company’s CEO, David Solomon, reportedly stated that trading revenue will likely fall by 10% in the third quarter due to sluggish conditions last month. However, Solomon noted that investment banking is improving, although activity from financial sponsors hasn’t rebounded as expected. He remains...
Gilead Sciences, Genesis Therapeutics Sign Deal to Discover, Develop Novel Therapies
Gilead Sciences, Genesis Therapeutics Sign Deal to Discover, Develop Novel Therapies
Sep 11, 2024
09:03 AM EDT, 09/10/2024 (MT Newswires) -- Gilead Sciences ( GILD ) and biotech firm Genesis Therapeutics said Tuesday that they have signed a strategic collaboration agreement to discover and develop novel, small molecule therapies intended for multiple targets. Under the terms of the deal, Genesis will receive an upfront cash payment of $35 million for three targets, and Gilead...
Copyright 2023-2026 - www.financetom.com All Rights Reserved